1.Antifungal Mechanism of Action of Lauryl Betaine Against Skin-Associated Fungus Malassezia restricta
Eunsoo DO ; Hyun Gee LEE ; Minji PARK ; Yong Joon CHO ; Dong Hyeun KIM ; Se Ho PARK ; Daekyung EUN ; Taehun PARK ; Susun AN ; Won Hee JUNG
Mycobiology 2019;47(2):242-249
Betaine derivatives are considered major ingredients of shampoos and are commonly used as antistatic and viscosity-increasing agents. Several studies have also suggested that betaine derivatives can be used as antimicrobial agents. However, the antifungal activity and mechanism of action of betaine derivatives have not yet been fully understood. In this study, we investigated the antifungal activity of six betaine derivatives against Malassezia restricta, which is the most frequently isolated fungus from the human skin and is implicated in the development of dandruff. We found that, among the six betaine derivatives, lauryl betaine showed the most potent antifungal activity. The mechanism of action of lauryl betaine was studied mainly using another phylogenetically close model fungal organism, Cryptococcus neoformans, because of a lack of available genetic manipulation and functional genomics tools for M. restricta. Our genome-wide reverse genetic screening method using the C. neoformans gene deletion mutant library showed that the mutants with mutations in genes for cell membrane synthesis and integrity, particularly ergosterol synthesis, are highly sensitive to lauryl betaine. Furthermore, transcriptome changes in both C. neoformans and M. restricta cells grown in the presence of lauryl betaine were analyzed and the results indicated that the compound mainly affected cell membrane synthesis, particularly ergosterol synthesis. Overall, our data demonstrated that lauryl betaine influences ergosterol synthesis in C. neoformans and that the compound exerts a similar mechanism of action on M. restricta.
Anti-Infective Agents
;
Betaine
;
Cell Membrane
;
Cryptococcus
;
Cryptococcus neoformans
;
Dandruff
;
Ergosterol
;
Fungi
;
Gene Deletion
;
Genetic Testing
;
Genomics
;
Humans
;
Malassezia
;
Methods
;
Skin
;
Transcriptome
2.Development of Agenda for Pharmaceutical Care Service Research and Development using the Analytical Hierarchy Process
Nayoung HAN ; Chae Reen JEONG ; Yun Kyoung SONG ; Jeong Hyun YOON ; Sunmee JANG ; Eui Kyung LEE ; Hyun Taek SHIN ; Young Sook LEE ; Hyun Soon SOHN ; Eunhee JI ; Dong Chul SUH ; Daekyung KIM ; Jung Mi OH
Korean Journal of Clinical Pharmacy 2019;29(1):45-55
BACKGROUND: Although the importance of pharmaceutical care service has been growing to meet the needs of customers with the improvement of clinical and humanistic outcomes, there was not a systematic strategy to promote research in Korea. The aim of this study was to suggest the core agendas for pharmaceutical care services research and development (R&D) considering priorities. METHODS: Based on desk researches, we developed R&D agendas for the needs of improving pharmaceutical care services in the area of institution, community, and public health. To determine the priority of agendas in developing pharmaceutical care service, analytic hierarchy process (AHP) analysis was performed by the 14 experts. Criteria and subcriteria were assessed for significance by pairwise comparisons. Then, agendas were evaluated for importance according to each subcriteria, and rank ordered considering the weight calculated by multiplying the importance scores of the criteria and the subcriteria. RESULTS: We derived 25 agendas including 13 for institutional pharmaceutical care service, 8 for community pharmaceutical care service, and 4 for public-health related pharmaceutical care service. AHP model was constructed based on 4 criteria and 8 subcriteria by a hierarchical structure. From the AHP survey, the ‘Development of pharmaceutical care service for metabolic and chronic disease’ agenda accounted for the highest priority. CONCLUSION: We have developed the R&D agendas of the pharmaceutical care service which should be promoted. The results should be utilized by the government to nationally support the development of the standards and relevant regulations related to pharmaceutical care services in Korea.
Korea
;
Pharmaceutical Services
;
Public Health
;
Social Control, Formal